Drug industry

Article Abstract:

Statistics of some of the companies in the Drug industry and their securities rankings as of January 21, 2005 are furnished. The recent downtrend in the sector on account of series of drug failures or withdrawals does not make the sector unattractive proposition at all. The investors have overreacted and so the stocks can be expected to return to the course.

Author: Rho, George, Ferro, Mario, Schlein, Milton, Clark, Charles, Butler, Jeremy J., Markey, Keith A., Rosner, Adam, Ferrara, J. Susan, Harris, Frederick L., Lewittes, William C.

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2005

Forecasts, trends, outlooks, Industry Overview, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

Abgenix Inc

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Abgenix Inc. from 1998 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

Author: Clark, Charles

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004

Sales, profits & dividends, Company sales and earnings, Company earnings/profit, Abgenix Inc., ABGX

User Contributions:

Comment about this article or add new information about this topic:

Subjects list: United States, Pharmaceutical industry, Securities, Company securities

Similar abstracts:

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.

Abstracts

Business, general

Drug industry

Abgenix Inc